HUM · Analysis updated Nov 6, 2026, 10:34 AM ET

Why is Humana Inc. (HUM) stock moving?

Humana's third-quarter adjusted loss of $0.70 a share was narrower than the roughly $1.00 loss analysts expected, and revenue rose 26% to $41.16 billion. The share of premiums spent on medical care (benefit ratio) was 93.7%, better than management's guidance of slightly above 94%. Humana raised its 2026 adjusted EPS outlook to at least $9.50 from at least $9.00, above the roughly $9.16-9.24 analysts expected. At about 10:25 AM ET the stock was $424.66, up 3.1% from $411.79, after trading as high as $444.

News behind the analysis

Humana beats estimates on earnings and revenue, raises guidance
Investing.com · Nov 5, 2026
Adjusted loss $0.70 vs $1.00 expected; revenue $41.16 billion (+26%); benefit ratio 93.7%; 2026 adjusted EPS at least $9.50 vs consensus $9.16.
Humana (NYSE:HUM) Posts Mixed Q3 Results and Raises FY2026 Adjusted EPS Guidance
ChartMill · Nov 5, 2026
Revenue within about 1% of estimates; adjusted results exclude a $358 million valuation item; stock indicated about 1.1% lower before the open.
Humana Raises Full-Year Profit Forecast Following Strong Third Quarter
Bloomberg · Nov 5, 2026
Lower medical costs drove the raise, capping a season of strong results for U.S. insurers.
Humana Q3 2026 Earnings Call Transcript
Benzinga · Nov 5, 2026
Cost trends in line to better than expected; strong 2028 bonus-year star ratings; investor update December 10.
Medicare Star Ratings Shift Advantage Away From CVS and UnitedHealth
Investing.com · Nov 5, 2026
CVS Health and UnitedHealth lost ground in the latest Medicare star ratings, which drive bonus payments.

In the Daily Standout

November 6, 2026: on the shortlist +3.12%

For informational and educational purposes only. Not investment advice. Prices are an intraday snapshot (about 10:25 AM ET) and move quickly; sentiment and confidence scores are model opinions, not guarantees. Do your own research.